➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Merck
Medtronic
Moodys
Colorcon

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

BETAPACE AF Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Betapace Af patents expire, and when can generic versions of Betapace Af launch?

Betapace Af is a drug marketed by Covis and is included in one NDA.

The generic ingredient in BETAPACE AF is sotalol hydrochloride. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

Drug patent expirations by year for BETAPACE AF
Drug Prices for BETAPACE AF

See drug prices for BETAPACE AF

Recent Clinical Trials for BETAPACE AF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Xinhua Hospital, Shanghai Jiao Tong University School of MedicinePhase 4
Beijing CTSmed Co. LtdPhase 4
Medtronic (Shanghai) Management Co. Ltd.Phase 4

See all BETAPACE AF clinical trials

Pharmacology for BETAPACE AF
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration

US Patents and Regulatory Information for BETAPACE AF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-006 Apr 2, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Covis BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-005 Mar 14, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Covis BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-007 Apr 2, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Covis BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-001 Feb 22, 2000 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Johnson and Johnson
Merck
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.